Director/PDMR Shareholding

RNS Number : 6537G

Biome Technologies PLC

16 May 2011

 



16th May 2011                                                                

Biome Technologies plc

 ("Biome" or "the Company")

Director/PDMR Shareholding

Biome was notified on 13 May 2011 of the following purchase by a person discharging material responsibilities:

Paul Law, managing director of the Bioplastics division, purchased 3,875,969 ordinary shares at 0.258 pence per share on 13 May 2011.  Following this transaction, Paul Law's total shareholding in Biome is 20,694,560 ordinary shares, representing 0.35% of the ordinary issued share capital of the Company.

In addition, Paul Law has unexercised options over 49,288,525 ordinary shares in aggregate. Paul Law also has an interest in the Company's shares through his participation in the Company's Public Equity Plan under which he was granted 140,000 points on 4 October 2010 (further information is set out in the Company's Annual Report and Financial Statements).

- Ends -

For further information please contact:

Biome Technologies plc                                           

Paul Mines, Chief Executive Officer

Sue Bygrave, Group Finance Director

www.biometechnologiesplc.com                                           Tel: [phone]

Daniel Stewart & Company plc                                 

Oliver Rigby (Nomad)

Martin Lampshire (Broker)

www.danielstewart.co.uk                                                        Tel: [phone]

First Columbus

John Nuttall/Chris Crawford/Kelly Gardiner               

www.first-columbus.com                                                       Tel: [phone]

Financial Dynamics                                                   

Oliver Winters                                                                         Tel: [phone]

Notes to Editors

Admitted to AIM in July 2010, the activities of Biome operate in two divisions; Bioplastics and Stanelco RF Technologies. Both divisions are underpinned by the Group's skills in the commercialisation and development of innovative technology.

The Group's core strategy is to develop and broaden its bioplastics business organically and is engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships.   These target applications in the food, horticulture and the electronics markets, amongst others, further enhance the Group's existing and new product development.

 

END

 

 

RDSLLFIIERIRLIL